Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai
Patent
1984-04-17
1985-08-06
Helfin, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
N-c doai
560 28, 560 10, C07C125065, C07C125067, A61K 3124
Patent
active
045336750
ABSTRACT:
The present invention consists of derivatives of colchicine and thiocolchicine which are carbamates of the same and are illustrated by the formula below: ##STR1## where either X.sub.1 or X.sub.2 is a hydroxy group and the other a lower alkoxy group and R.sub.1 can be H or an alkyl, R.sub.2 an alkyl, alkenyl or aryl which may be substituted and R.sub.3 is either OCH.sub.3 or SCH.sub.3 ; alkyl and alkoxy=C.sub.1 -C.sub.6 ; aryl=monoaryl.
These compounds are not only new but have exhibited antitumor activity binding to tubulin protein and tests against P388 lymphocytic leukemia and also active against gouty arthritis. Further, they are far less toxic than colchicine.
REFERENCES:
Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 6th ed., (1980), 718.
Raffauf et al., Jour. Amer. Chem. Soc., vol. 75, (1953), 5292-5294.
Capraro et al., Helv. Chim. Acta, vol. 62, (1979), 965-970.
Velluz et al., Bull. Chim. Soc. Fr., (1954), 1072-1075; 194-197.
Roche, Design of Biopharmaceutical Properties through Prodrugs and Analogs, (1977), 234.
Brossi Arnold
Kerekes Peter
Helfin Bernard
Roberts, Jr. John S.
The United States of America as represented by the Department of
LandOfFree
Carbamates of colchicine for treatment of gout does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamates of colchicine for treatment of gout, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamates of colchicine for treatment of gout will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-512999